Mou F, Huang Z, Cheng Y, Zhao X, Sun X, Li H
Ther Adv Drug Saf. 2024; 15:20420986241303432.
PMID: 39703773
PMC: 11656427.
DOI: 10.1177/20420986241303432.
Pena J, Cotabarren I, Gallo L
Pharmaceutics. 2024; 16(8).
PMID: 39204414
PMC: 11359400.
DOI: 10.3390/pharmaceutics16081069.
Lara-Sanchez M, Ganem-Rondero A, Nava-Arzaluz M, Becerril-Osnaya A, Perez-Carranza L, Alcala-Alcala S
AAPS PharmSciTech. 2024; 25(7):197.
PMID: 39174702
DOI: 10.1208/s12249-024-02914-7.
Viegas S, Marinheiro D, Bastos V, Daniel-da-Silva A, Vieira R, Oliveira H
Polymers (Basel). 2024; 16(7).
PMID: 38611137
PMC: 11013690.
DOI: 10.3390/polym16070879.
Pyrak B, Rogacka-Pyrak K, Gubica T, Szeleszczuk L
Int J Mol Sci. 2024; 25(6).
PMID: 38542499
PMC: 10971266.
DOI: 10.3390/ijms25063527.
Physiologically based pharmacokinetic modeling of imatinib and N-desmethyl imatinib for drug-drug interaction predictions.
Loer H, Kovar C, Rudesheim S, Marok F, Fuhr L, Selzer D
CPT Pharmacometrics Syst Pharmacol. 2024; 13(6):926-940.
PMID: 38482980
PMC: 11179706.
DOI: 10.1002/psp4.13127.
Development of Sustained Release System Based on High Water-Absorbable Gel Formation Using Croscarmellose Sodium, Alkaline Excipients and HPMC (ACSH SR System); Novel Application of Croscarmellose Sodium as a Gel Former.
Gomi M, Mizutani N, Senoo R, Matsubara N, Watanabe A, Maruyama M
Pharm Res. 2023; 40(12):3073-3086.
PMID: 37964084
DOI: 10.1007/s11095-023-03630-w.
Carvacrol-Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE-Aided Optimization, and in vitro/in vivo Evaluation.
Tafish A, El-Sherbiny M, Al-Karmalawy A, Soliman O, Saleh N
Int J Nanomedicine. 2023; 18:5749-5780.
PMID: 37849641
PMC: 10578319.
DOI: 10.2147/IJN.S421617.
Dual-Functional Drug Delivery System for Bisphosphonate-Related Osteonecrosis Prevention and Its Bioinspired Releasing Model and In Vitro Assessment.
Sungkhaphan P, Thavornyutikarn B, Muangsanit P, Kaewkong P, Kitpakornsanti S, Pornsuwan S
ACS Omega. 2023; 8(29):26561-26576.
PMID: 37521598
PMC: 10373185.
DOI: 10.1021/acsomega.3c03440.
The Influence of Shape Parameters on Unidirectional Drug Release from 3D Printed Implants and Prediction of Release from Implants with Individualized Shapes.
Domsta V, Hansch C, Lenz S, Gao Z, Matin-Mann F, Scheper V
Pharmaceutics. 2023; 15(4).
PMID: 37111760
PMC: 10143641.
DOI: 10.3390/pharmaceutics15041276.
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.
DAngelo D, Quarta E, Glieca S, Varacca G, Flammini L, Bertoni S
Pharmaceutics. 2023; 15(3).
PMID: 36986883
PMC: 10055879.
DOI: 10.3390/pharmaceutics15031023.
The Increased Release Kinetics of Quercetin from Superparamagnetic Nanocarriers in Dialysis.
Mandic L, Matkovic M, Baranovic G, Segota S
Antioxidants (Basel). 2023; 12(3).
PMID: 36978980
PMC: 10045069.
DOI: 10.3390/antiox12030732.
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions.
Loer H, Feick D, Rudesheim S, Selzer D, Schwab M, Teutonico D
CPT Pharmacometrics Syst Pharmacol. 2023; 12(5):724-738.
PMID: 36808892
PMC: 10196430.
DOI: 10.1002/psp4.12946.
Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039.
Kourentas A, Gajewska M, Lin W, Dhareshwar S, Steib-Lauer C, Kulkarni S
AAPS J. 2023; 25(1):25.
PMID: 36788163
DOI: 10.1208/s12248-023-00787-5.
How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.
Akhuemokhan P, Green N, Haddrell A, Lewis D, Reid J, Forbes B
Int J Pharm. 2023; 634:122676.
PMID: 36738807
PMC: 10685293.
DOI: 10.1016/j.ijpharm.2023.122676.
Evaluation of Cell Proliferation and Wound Healing Effects of Vitamin A Palmitate-Loaded PLGA/Chitosan-Coated PLGA Nanoparticles: Preparation, Characterization, Release, and Release Kinetics.
Baghirova L, Kaya Tilki E, Ozturk A
ACS Omega. 2023; 8(2):2658-2668.
PMID: 36687101
PMC: 9851036.
DOI: 10.1021/acsomega.2c07232.
Development of a Physiologically Based Pharmacokinetic Model for Tegoprazan: Application for the Prediction of Drug-Drug Interactions with CYP3A4 Perpetrators.
Ngo L, Lee J, Yun H, Chae J
Pharmaceutics. 2023; 15(1).
PMID: 36678810
PMC: 9862396.
DOI: 10.3390/pharmaceutics15010182.
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A.
Becker T, Krome A, Vahdati S, Schiefer A, Pfarr K, Ehrens A
Pharmaceutics. 2022; 14(8).
PMID: 36015283
PMC: 9414514.
DOI: 10.3390/pharmaceutics14081657.
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs.
Wu D, Sanghavi M, Kollipara S, Ahmed T, Saini A, Heimbach T
Pharm Res. 2022; 40(2):337-357.
PMID: 35840856
DOI: 10.1007/s11095-022-03319-6.
Niosomes encapsulated in biohydrogels for tunable delivery of phytoalexin resveratrol.
Machado N, Fernandez M, Haring M, Saldias C, Diaz D
RSC Adv. 2022; 9(14):7601-7609.
PMID: 35521173
PMC: 9061210.
DOI: 10.1039/c8ra09655d.
